rhenium has been researched along with Breast Neoplasms in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.56) | 18.7374 |
1990's | 13 (18.06) | 18.2507 |
2000's | 33 (45.83) | 29.6817 |
2010's | 17 (23.61) | 24.3611 |
2020's | 5 (6.94) | 2.80 |
Authors | Studies |
---|---|
Cao, Q; Ling, Y; Liu, B; Mao, ZW; Su, X; Wang, WJ; Zhang, H; Zhou, X | 1 |
Collery, P; Desmaële, D; Harikrishnan, A; Lakshmi, B; Veena, V | 1 |
Antomarchi, J; Cohen, C; Collery, P; Guigonis, JM; Krossa, I; Lagadec, P; Lucio, M; Schmid-Alliana, A; Schmid-Antomarchi, H; Scimeca, JC; Varlet, D | 1 |
Collery, P; Guigonis, JM; Lucio, M; Michalke, B; Schmid-Alliana, A; Schmid-Antomarchi, H; Scimeca, JC; Varlet, D | 1 |
Collery, P; Desmaele, D; Harikrishnan, A; Khanna, S; Lakshmi, B; Veena, V | 1 |
Badiavas, K; Doumas, A; Farmakis, G; Frangos, S; Iakovou, I; Mpalaris, V | 1 |
Bertrand, HC; Clède, S; Guillot, R; Lambert, F; Policar, C | 1 |
Brackstone, M; Gupta, V; Kidane, B; Whiston, C; Wright, F; Zabel, PL | 1 |
Cheng, PC; Chiang, PF; Chuang, TW; Lin, WJ; Luo, TY; Yeh, CH | 1 |
Belchior, A; Correia, JD; Fernandes, C; Gano, L; Marques, F; Monteiro, S; Santos, I | 1 |
Bernard, JM; Carrington, SJ; Chakraborty, I; Mascharak, PK | 1 |
Chao, Y; Cheng, L; Gao, M; Liang, C; Liu, J; Liu, Z; Wang, G; Yang, K; Yi, X; Zhong, X | 1 |
Bensimhon, L; Guilhot, J; Métayé, T; Perdrisot, R | 1 |
Hsu, KL; Kung, HC; Lai, PS; Lin, WJ; Liu, SW; Luo, TY; Tang, IC; Wu, YL | 1 |
de Klerk, JM; Hoekstra, A; Lam, MG; van Rijk, PP; Zonnenberg, BA | 1 |
Chen, KT; Lee, TW; Lo, JM | 1 |
Huang, L; Shen, YM; Sun, Y; Xu, X; Zhang, Y; Zhu, H | 1 |
Cui, W; Huang, L; Shen, YM; Xu, X; Yang, G; Zhang, Y; Zhu, H | 1 |
Gourni, E; Kiaris, H; Lafkas, D; Loudos, G; Papadopoulos, M; Paravatou-Petsotas, M; Pelecanou, M; Pirmettis, IC; Sagnou, M; Tzanopoulou, S; Varvarigou, A; Xanthopoulos, S | 1 |
Bao, A; Goins, B; Hrycushko, BA; Li, S; Liu, Y; Otto, PM; Phillips, WT; Shi, C | 1 |
Baziotis, N; Limouris, GS; Zafeirakis, A; Zissimopoulos, A | 1 |
Bartal, A; Bidlek, M; Dorogi, B; Godény, M; Kásler, M; Mátrai, Z; Saeki, T; Sávolt, A; Sinkovics, I; Takeuchi, H; Tóth, L | 1 |
Hu, W; Merz, K; Neundorf, I; Schatzschneider, U; Splith, K | 1 |
Gano, L; Marques, F; Neto, C; Oliveira, MC; Santos, I; Thiemann, T | 1 |
Baines, L; Buckenmaier, CC; Howard, RS; Radowsky, JS; Shriver, CD; Stojadinovic, A | 1 |
Badawi, A; Collery, P; Collery, T; D'Angelo, J; Desmaele, D; Kermagoret, A; Mohsen, A; Morgant, G; Tomas, A; Wei, M | 1 |
Benoit, L; Fraisse, J; Hoyek, T | 1 |
Benamor, M; Clough, KB; Fréneaux, P; Nos, C | 1 |
Kasumi, F; Koizumi, M; Makita, M; Nomura, E; Ogata, E; Sakamoto, G; Takiguchi, T; Tanaka, K; Yamada, Y; Yoshimoto, M | 1 |
Asoglu, O; Berberoglu, K; Bozfakioglu, Y; Cantez, S; Eroglu, A; Mudun, A; Muslumanoglu, M; Ozmen, V; Tuzlali, S; Yavuz, E | 1 |
de Klerk, JM; Lam, MG; van Rijk, PP | 1 |
Akiyama, F; Iwase, T; Kasumi, F; Koizumi, M; Makita, M; Nishimura, S; Nomura, E; Sakamoto, G; Tada, K; Tada, T; Takahashi, K; Takiguchi, T; Yamada, Y; Yoshimoto, M | 1 |
Bleichrodt, R; Heider, KH; Koppe, M; Kuthan, H; Leeuwen, Pv; Roos, J; Schaijk, Fv | 1 |
Chen, SX; DU, JQ; Jiang, NY; Liang, JG; Liu, XG; Lu, XP | 1 |
Iwase, T; Kasumi, F; Koizumi, M; Koyama, M; Makita, M; Miyagi, Y; Morota, S; Nishimura, SI; Sugihara, T; Tada, KI; Yoshimoto, M | 1 |
Livaniou, E; Papadopoulos, M; Paravatou-Petsotas, M; Patsis, G; Pelecanou, M; Pirmettis, IC; Tzanopoulou, S | 1 |
Li, GP; Wang, YX; Zhang, YF | 1 |
Chen, Y; He, L; Huang, Z; Xiong, Q; Yang, X | 1 |
De Arriba, A; Garcia-Talavera, JR; Gonzalez-Orus, J; Iglesias, M; Macias, MC; Ramos, M; Ruano, R; Serrano, E | 1 |
Cantez, S; Eroglu, A; Igci, A; Mudun, A; Muslumanoglu, M; Ozel, S; Ozmen, V; Sanli, Y; Turkmen, C; Tuzlali, S; Yavuz, E | 1 |
Koutsikos, J; Leondi, A | 1 |
Aravantinos, D; Gerali, S; Karapas, N; Keramopoulos, A | 1 |
Blijham, GH; de Klerk, JM; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA | 1 |
Silberstein, EB | 1 |
Wagner, HN | 1 |
Bender, H; Biersack, HJ; Dierke-Dzierzon, C; Grünwald, F; Mallmann, P; Palmedo, H; Reichmann, K; Schomburg, A; Schöneich, G; Zamorra, P | 1 |
Botha, JM; Doman, MJ; Goedhals, L; Lötter, MG; Marais, J; Naudé, H; Otto, AC; Roodt, A; van Aswegen, A | 1 |
Biersack, HJ; Dierke-Dzierzon, C; Müller, SC; Palmedo, H; Schoeneich, G | 1 |
Biersack, HJ; Dierke-Dzierzon, C; Hauswirth, AE; Krebs, D; Palmedo, H | 1 |
Biersack, HJ; Grünwald, F; Köhler, S; Krebs, D; Palmedo, H; Wagner, U | 1 |
Baron, J; Cohen, M; Schneebaum, S; Skornick, Y; Stadler, J; Yaniv, D | 1 |
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonneberg, BA | 1 |
Bender, H; Biersack, HJ; Carl, UM; Dierke-Dzierzon, C; Krebs, D; Palmedo, H; Risse, J | 1 |
Liu, TJ; Tsai, SC; Wang, SJ | 1 |
Spencer, RP | 1 |
Csernay, L; Láng, J; Pajor, L; Pávics, L; Róka, R; Séra, T; Thurzó, L | 1 |
DeNardo, GL | 1 |
Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A | 1 |
Carpentier, P; Caty, A; Depreux, P; Kolesnikov-Gauthier, H; Sulman, C; Vennin, P | 1 |
Franke, WG; Hliscs, R; Koch, R; Kropp, J; Liepe, K; Runge, R | 1 |
Kimijima, I; Ohtake, T; Shishido, F; Takenoshita, S; Tsuchiya, A; Watanabe, T | 1 |
Badriyyah, M; Chisin, R; Freund, HR; Klein, M; Nissan, A; Prus, D; Spira, RM; Zamir, O | 1 |
Bergomi, S; Festa, A; Maini, CL; Pasqualoni, R; Rea, S; Sciuto, R; Semprebene, A | 1 |
Jaouen, G; Le Bideau, F; Salmain, M; Top, S | 1 |
Allen, B; Campbell, I; Desai, S; Dray, M; Scarlet, J | 1 |
Davis, J; Hannon, MJ; Jackson, A; Pither, RJ; Rodger, A | 1 |
Azmy, IA; Rogers, C | 1 |
Katzenellenbogen, JA; Mull, ES; Rodriguez, AL; Sattigeri, VJ | 1 |
de Klerk, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA | 1 |
Terui, S; Yamamoto, H | 1 |
Ebuchi, M; Horiuchi, J; Matsubara, S; Okuyama, T; Shibuya, H; Suzuki, H; Suzuki, S; Umehara, I | 1 |
Chevallier, J; Martin, P; Reboul, F; Robin, M; Serin, D; Vinot, JM | 1 |
1 review(s) available for rhenium and Breast Neoplasms
Article | Year |
---|---|
186Re-HEDP for metastatic bone pain in breast cancer patients.
Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Maximum Tolerated Dose; Organometallic Compounds; Pain; Palliative Care; Radiation Injuries; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Treatment Outcome | 2004 |
15 trial(s) available for rhenium and Breast Neoplasms
Article | Year |
---|---|
Pain palliative therapy in women with breast cancer osseous metastatic disease and the role of specific serum cytokines as prognostic factors.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Cytokines; Female; Humans; Interleukin-6; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Rhenium; Strontium Radioisotopes | 2014 |
Pain ratings by patients and their providers of radionucleotide injection for breast cancer lymphatic mapping.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cohort Studies; Female; Humans; Injections; Lidocaine; Lymph Nodes; Middle Aged; Pain; Pain Measurement; Patients; Physicians; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Sulfur Colloid | 2012 |
Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study.
Topics: Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Rhenium; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Compounds | 2003 |
Radioguided sentinel node detection in breast cancer patients: comparison of 99mTc phytate and 99mTc rhenium colloid efficacy.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Organotechnetium Compounds; Phytic Acid; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Rhenium; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Compounds | 2004 |
[Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis].
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Pain; Pain Management; Pamidronate; Radioisotopes; Rhenium | 2005 |
Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Humans; Image Enhancement; Injections, Intralesional; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Rhenium; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Sulfides | 2008 |
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.
Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Palliative Care; Radioisotopes; Rhenium; Thrombocytopenia | 1996 |
Dosage and response in radiopharmaceutical therapy of painful osseous metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Male; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia | 1996 |
[Pain therapy with rhenium-186 HEDP in multiple bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Male; Neoplasm Metastasis; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors; Tomography, Emission-Computed | 1996 |
Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors | 1997 |
186Re-etidronate in breast cancer patients with metastatic bone pain.
Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Organometallic Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Rhenium | 1999 |
[Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
Topics: Alkaline Phosphatase; Analgesics; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome | 2000 |
Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Time Factors | 2000 |
[Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Strontium Radioisotopes; Tomography, X-Ray Computed | 2000 |
Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Etidronic Acid; Female; Humans; Infusions, Intravenous; Karnofsky Performance Status; Middle Aged; Organometallic Compounds; Pain Measurement; Pain, Intractable; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium Radioisotopes; Treatment Outcome | 2001 |
56 other study(ies) available for rhenium and Breast Neoplasms
Article | Year |
---|---|
A Carbonic Anhydrase IX (CAIX)-Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti-Tumor Immunity.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Death; Cell Line; Cell Proliferation; Coordination Complexes; Dendritic Cells; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Photochemotherapy; Photosensitizing Agents; Pyroptosis; Rhenium; Structure-Activity Relationship; T-Lymphocytes; Tumor Hypoxia; Tumor Microenvironment | 2022 |
Effects of Rhenium(I)-diselenoether and of its Diselenide Ligand on the Production of Cathepsins B and S by MDA-MB231 Breast Malignant Cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cathepsin B; Cathepsins; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Molecular Structure; Rhenium | 2021 |
Relationship between the oxidative status and the tumor growth in transplanted triple-negative 4T1 breast tumor mice after oral administration of rhenium(I)-diselenoether.
Topics: Administration, Oral; Advanced Oxidation Protein Products; Animals; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Mice; Mice, Inbred BALB C; Oxidative Stress; Rhenium; Triple Negative Breast Neoplasms; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2022 |
Plasma Rhenium and Selenium Concentrations After Repeated Daily Oral Administration of Rhenium(I)-diselenoether in 4T1 Breast Tumor-bearing Mice.
Topics: Administration, Oral; Animals; Biological Assay; Breast Neoplasms; Female; Humans; Mammary Neoplasms, Animal; Mice; Rhenium; Selenium | 2023 |
A New Model Applied for Evaluating a Rhenium-diselenium Drug: Breast Cancer Cells Stimulated by Cytokines Induced from Polynuclear Cells by LPS.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor I; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Primary Cell Culture; Reactive Oxygen Species; Rhenium; Selenium; Transforming Growth Factor beta; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2020 |
Luminescence modulations of rhenium tricarbonyl complexes induced by structural variations.
Topics: Alkylation; Breast Neoplasms; Cell Line, Tumor; Coordination Complexes; Female; Humans; Luminescence; Luminescent Agents; Luminescent Measurements; Optical Imaging; Rhenium; Triazoles | 2014 |
Cysteine rhenium colloid: a novel radiocolloid for identifying sentinel lymph nodes in breast cancer surgery.
Topics: Aged; Breast Neoplasms; Colloids; Cysteine; Female; Humans; Intraoperative Period; Lymphatic Metastasis; Mastectomy; Middle Aged; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Rhenium; Sentinel Lymph Node Biopsy | 2015 |
188Re-HYNIC-trastuzumab enhances the effect of apoptosis induced by trastuzumab in HER2-overexpressing breast cancer cells.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Flow Cytometry; Humans; Hydrazines; Membrane Potential, Mitochondrial; Nicotinic Acids; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptor, ErbB-2; Rhenium; Trastuzumab | 2015 |
Novel (188)Re multi-functional bone-seeking compounds: Synthesis, biological and radiotoxic effects in metastatic breast cancer cells.
Topics: Animals; Biological Transport; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Durapatite; Female; Mice; Neoplasm Metastasis; Organometallic Compounds; Radioisotopes; Rhenium; Tissue Distribution | 2016 |
A Theranostic Two-Tone Luminescent PhotoCORM Derived from Re(I) and (2-Pyridyl)-benzothiazole: Trackable CO Delivery to Malignant Cells.
Topics: Benzothiazoles; Breast Neoplasms; Carbon Monoxide; Cell Line, Tumor; Crystallography, X-Ray; Drug Carriers; Drug Delivery Systems; Female; Humans; Luminescence; Magnetic Resonance Spectroscopy; Myoglobin; Organometallic Compounds; Prodrugs; Pyridines; Rhenium; Spectrometry, Fluorescence; Theranostic Nanomedicine | 2016 |
Rhenium-188 Labeled Tungsten Disulfide Nanoflakes for Self-Sensitized, Near-Infrared Enhanced Radioisotope Therapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disulfides; Female; Hyperthermia, Induced; Immunohistochemistry; Mice; Mice, Inbred BALB C; Photochemotherapy; Radioisotopes; Rhenium; Tungsten | 2016 |
Influence of temperature on the radiochemical purity of 99mTc-colloidal rhenium sulfide for use in sentinel node localization.
Topics: Breast Neoplasms; Chlorides; Chromatography, Paper; Female; Filtration; Humans; Lymph Nodes; Lymphatic Metastasis; Particle Size; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Sodium Pertechnetate Tc 99m; Sulfides; Technetium Tc 99m Sulfur Colloid; Temperature | 2008 |
Evaluating the potential of 188Re-SOCTA-trastuzumab as a new radioimmunoagent for breast cancer treatment.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cross-Linking Reagents; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Organometallic Compounds; Radiochemistry; Radioimmunotherapy; Radioisotopes; Receptor, ErbB-2; Rhenium; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staining and Labeling; Temperature; Time Factors; Trastuzumab | 2009 |
Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rhenium; Safety; Samarium; Strontium; Strontium Radioisotopes | 2009 |
In vivo examination of (188)Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Radioimmunotherapy; Radioisotopes; Receptor, ErbB-2; Rhenium; Staining and Labeling; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Trastuzumab | 2009 |
Design, synthesis, and evaluation of cyclofenil derivatives for potential SPECT imaging agents.
Topics: Breast Neoplasms; Cyclofenil; Drug Design; Drug Stability; Humans; Ligands; Octanols; Organotechnetium Compounds; Receptors, Estrogen; Rhenium; Tomography, Emission-Computed, Single-Photon; Water | 2010 |
Synthesis and binding affinities of Re(I) and (99m)Tc(I)-containing 16alpha-substituted estradiol complexes: Models for potential breast cancer imaging agents.
Topics: Animals; Binding, Competitive; Breast Neoplasms; Cattle; Diagnostic Imaging; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Hydrophobic and Hydrophilic Interactions; Organotechnetium Compounds; Protein Binding; Rhenium | 2010 |
Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.
Topics: Animals; Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Radiopharmaceuticals; Rhenium; Structure-Activity Relationship; Technetium; Tissue Distribution; Transplantation, Heterologous | 2010 |
Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes.
Topics: Animals; Axilla; Brachytherapy; Breast Neoplasms; Feasibility Studies; Female; Humans; Liposomes; Lymph Nodes; Lymphatic Irradiation; Mastectomy, Segmental; Nanoparticles; Neoplasm, Residual; Radioisotopes; Radiotherapy Dosage; Rhenium | 2011 |
Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium | 2011 |
[The potential role of SPECT/CT in the preoperative detection of sentinel lymph nodes in breast cancer].
Topics: Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Neoplasm Staging; Organotechnetium Compounds; Phytic Acid; Radiopharmaceuticals; Rhenium; Sentinel Lymph Node Biopsy; Technetium Compounds; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Sulfur Colloid; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Influence of the metal center and linker on the intracellular distribution and biological activity of organometal-peptide conjugates.
Topics: Amino Acid Sequence; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Cell-Penetrating Peptides; Female; Humans; Manganese; Models, Molecular; Molecular Sequence Data; Organometallic Compounds; Rhenium; Solid-Phase Synthesis Techniques | 2012 |
Novel estradiol based metal complexes of Tc-99m.
Topics: Binding, Competitive; Breast Neoplasms; Cell Line, Tumor; Estradiol; Female; Humans; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Chemical; Molecular Structure; Organometallic Compounds; Receptors, Estrogen; Rhenium; Technetium | 2012 |
Combination of three metals for the treatment of cancer: gallium, rhenium and platinum. 1. Determination of the optimal schedule of treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Coordination Complexes; Drug Synergism; Female; Gallium; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Rhenium; Xenograft Model Antitumor Assays | 2012 |
[The sentinal node: the Dijon experience].
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Coloring Agents; False Negative Reactions; Feasibility Studies; Female; France; Gamma Cameras; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; Rhenium; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium | 2002 |
Impact of internal mammary sentinel node imaging in breast cancer.
Topics: Adenocarcinoma; Adult; Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Sentinel Lymph Node Biopsy; Technetium Compounds; Tissue Distribution | 2003 |
Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer.
Topics: Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Injections, Intradermal; Injections, Intralesional; Lymph Nodes; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Compounds; Technetium Tc 99m Sulfur Colloid | 2004 |
Safety, pharmacokinetics, immunogenicity, and biodistribution of (186)Re-labeled humanized monoclonal antibody BIWA 4 (Bivatuzumab) in patients with early-stage breast cancer.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Glycoproteins; Humans; Hyaluronan Receptors; Middle Aged; Prospective Studies; Radioimmunodetection; Radioisotopes; Rhenium; Safety | 2004 |
Radioactivity thresholds for sentinel node biopsy in breast cancer.
Topics: Axilla; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Lymph Nodes; Organotechnetium Compounds; Phytic Acid; Radiation Dosage; Radiopharmaceuticals; Rhenium; Sentinel Lymph Node Biopsy; Technetium Compounds | 2006 |
Synthesis, characterization, and biological evaluation of M(I)(CO)3(NNO) complexes (M = Re, 99mTc) conjugated to 2-(4-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.
Topics: Animals; Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Cell Line; Cell Line, Tumor; Female; Fibroblasts; Humans; Mice; Organometallic Compounds; Radiopharmaceuticals; Rhenium; Structure-Activity Relationship; Technetium; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2006 |
[188Re-labeled herceptin inhibits proliferation of breast cancer cell line SKBR-3 in vitro].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Immunotoxins; Proto-Oncogene Mas; Radioisotopes; Receptor, ErbB-2; Rhenium; Trastuzumab | 2006 |
Preparation and imaging research on 188Re-DTPA-deoxyglucose in MCF-7 tumor-bearing mice.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Deoxyglucose; Female; Humans; Mice; Mice, Nude; Pentetic Acid; Radiography; Radioisotopes; Rhenium; Transplantation, Heterologous | 2007 |
Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Palpation; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2008 |
Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium | 2008 |
[Internal breast scintigraphy using rhenium 99mTc. Contribution to delimiting the area of radiotherapy of cancer].
Topics: Breast Neoplasms; Female; Ganglia; Humans; Lymphography; Radionuclide Imaging; Rhenium; Technetium; Technetium Compounds | 1983 |
1996 SNM annual meeting: medical problem solving.
Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Radiation dose estimates of 186Re-hydroxyethylidene diphosphonate for palliation of metastatic osseous lesions: an animal model study.
Topics: Adult; Animals; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Organometallic Compounds; Palliative Care; Papio; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Tissue Distribution; Urinary Bladder | 1997 |
[Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP].
Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Middle Aged; Pain Measurement; Palliative Care; Quality of Life; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome | 1998 |
Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Etidronic Acid; Female; Humans; Middle Aged; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate | 1998 |
Gamma probe-guided sentinel node biopsy--optimal timing for injection.
Topics: Adult; Aged; Axilla; Biopsy; Breast Neoplasms; Colloids; Female; Gamma Rays; Humans; Injections; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium | 1998 |
Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases.
Topics: Adult; Aged; Analgesics; Blood Cell Count; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Injections, Intravenous; Middle Aged; Pain; Pain Measurement; Palliative Care; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome | 1999 |
Lymphoscintigraphy using larger colloid particles may enhance visualization of the sentinel node in breast cancer: a case report.
Topics: Adult; Breast Neoplasms; Colloids; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Particle Size; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Sulfur Colloid | 2000 |
Quantifying leukocyte and thrombocyte suppression-recovery after Re-186 HEDP for bone metastases.
Topics: Blood Platelets; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Carcinoma; Etidronic Acid; Female; Follow-Up Studies; Forecasting; Humans; Leukocyte Count; Leukocytes; Leukopenia; Organometallic Compounds; Platelet Count; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Tin Radioisotopes | 2000 |
Biotherapy of cancer marches on!
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Rhenium; Trastuzumab | 1998 |
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium | 2000 |
Sentinel node biopsy with technetium-99m colloidal rhenium sulphide in patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Rhenium; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2001 |
[Sentinel lymph node biopsy in breast cancer: a validation study and preliminary results].
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; False Positive Reactions; Female; Humans; Keratins; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Rhenium; Sentinel Lymph Node Biopsy; Technetium Compounds | 2001 |
New and efficient routes to biomolecules substituted with cyclopentadienyltricarbonylrhenium and -technetium derivatives.
Topics: Breast Neoplasms; Chemistry, Pharmaceutical; Cyclopentanes; Estrogens; Half-Life; Molecular Structure; Octreotide; Organometallic Compounds; Organotechnetium Compounds; Peptides; Proteins; Radioisotopes; Radiopharmaceuticals; Rhenium; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Technetium Tc 99m Sestamibi | 2001 |
Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimony; Axilla; Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Sentinel Lymph Node Biopsy; Technetium Compounds | 2001 |
Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells.
Topics: Biological Transport; Breast Neoplasms; Catalysis; Dimethyl Sulfoxide; Endoplasmic Reticulum; Ethinyl Estradiol; Female; Humans; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Structure; Organometallic Compounds; Platinum; Pyridines; Receptors, Estrogen; Rhenium; Stereoisomerism; Tumor Cells, Cultured | 2001 |
Sentinel node biopsy with technetium-99m colloidal rhenium sulphide in patients with breast cancer (Br J Surg 2001; 88: 704-7).
Topics: Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2001 |
Aryl cyclopentadienyl tricarbonyl rhenium complexes: novel ligands for the estrogen receptor with potential use as estrogen radiopharmaceuticals.
Topics: Breast Neoplasms; Estrogens; Female; Humans; Ligands; Models, Molecular; Organometallic Compounds; Protein Binding; Radioisotopes; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Estrogen; Rhenium; Structure-Activity Relationship | 2002 |
Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Half-Life; Humans; Male; Middle Aged; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium | 1992 |
New simplified lymphoscintigraphic technique in patients with breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Methods; Radiography, Thoracic; Radionuclide Imaging; Rhenium; Technetium; Technetium Compounds; Thorax | 1989 |
Radionuclide lymphoscintigraphy performed on the mastectomized chest wall.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphoscintigraphy; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Rhenium; Technetium; Technetium Compounds | 1986 |
[The value of breast lymphoscintigraphy in the definition of axillary staging in cancer of the breast].
Topics: Axilla; Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Radioisotopes; Radionuclide Imaging; Rhenium | 1986 |